UNSPSC 51284149: Ceftizoxime sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C13H12N5O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26337D5X88, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)-(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6r-(6-alpha,7-beta(z)))- but more generally known as ceftizoxime sodium, which bears US NIH Compound Identifier 9570777.

UNSPSC 51284149 Ceftizoxime sodium, a Commodity code, does not reflect meaningful recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities tagged under this code — a completed Illinois Department of Public Health piggyback pharmaceutical award (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and a Seminole County, Florida procurement for Naloxone and drug deactivation systems — involve different active pharmaceutical ingredients and product categories that fall outside ceftizoxime's core antibiotic classification. State and local health departments and county procurement offices occasionally index pharmaceutical purchases under broad or misaligned UNSPSC codes during tagging, but the recent record here shows no solicitations specifically for ceftizoxime sodium or related third-generation cephalosporins.

Watch this code rather than pursue it at present. The Illinois and Florida opportunities suggest that state health agencies and county health systems do acquire pharmaceuticals through competitive sealed bidding and cooperative purchasing vehicles (MMCAP in Illinois), and they structure awards with multi-year terms and quarterly or recurring delivery cycles — a pattern that could apply to ceftizoxime procurement if it were solicited. However, the absence of recent ceftizoxime-specific opportunities and the mismatch between the code's designation and actual recent buys mean there is no current pipeline to evaluate. Firms holding ceftizoxime or broad antibiotic supply agreements should monitor state department of health and county health system RFPs and piggyback cooperative purchasing notices for pharmaceutical commodities more broadly, rather than tracking this specific code.